deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02458183

Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS (Venus)

A Multinational, Multicenter, Randomized, Comparative, Open-label, Phase 3 Study to Assess the Immunogenicity and Safety of DTaP-IPV (Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus) Vaccine Administered to Healthy Infants

Sponsor: Boryung Pharmaceutical Co., Ltd

Conditions Diphtheria Pertussis Poliomyelitis Tetanus
Interventions DTaP vaccine and IPV vaccine DTaP-IPV combination vaccine
Updated 10 times since 2017 Last updated: Jun 25, 2023 Started: Feb 2, 2015 Primary completion: Dec 19, 2017 Completion: May 5, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Diphtheria and Pertussis, this trial is completed. The trial is conducted by Boryung Pharmaceutical Co., Ltd and has accumulated 10 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshotRecruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Feb 2020 · 20 months · monthly snapshotActive Not Recruiting~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2023 · 30 months · monthly snapshotUnknown Status~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jul 2023 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Unknown Status → Completed

  5. Jan 2021 — Jul 2023 [monthly]

    Unknown Status PHASE3

▶ Show 5 earlier versions

  1. Feb 2020 — Jan 2021 [monthly]

    Unknown Status PHASE3

    Status: Active Not Recruiting → Unknown Status

  2. Jun 2018 — Feb 2020 [monthly]

    Active Not Recruiting PHASE3

  3. Feb 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  4. Feb 2017 — Feb 2018 [monthly]

    Recruiting PHASE3

  5. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boryung Pharmaceutical Co., Ltd
Data source: Boryung Pharmaceutical Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations